<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC_13(5-6)_183</article-id>
<article-id pub-id-type="doi">10.15836/ccar2018.183</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Primary mitral regurgitation according to gender</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8502-7816</contrib-id><name><surname>Gulin</surname><given-names>Dario</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5989-6495</contrib-id><name><surname>Pa&#x0161;ali&#x0107;</surname><given-names>Ante</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8664-3338</contrib-id><name><surname>Planini&#x0107;</surname><given-names>Zrinka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7904-8899</contrib-id><name><surname>Per&#x010D;i&#x0107;</surname><given-names>Marko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3189-8661</contrib-id><name><surname>Fri&#x0161;&#x010D;i&#x0107;</surname><given-names>Tea</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0555-6863</contrib-id><name><surname>Adrovi&#x0107;</surname><given-names>Leon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9701-0253</contrib-id><name><surname>Be&#x0161;i&#x0107;</surname><given-names>Dijana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4488-0559</contrib-id><name><surname>&#x0160;iki&#x0107;</surname><given-names>Jozica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital &#x201C;Sveti Duh&#x201D;</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Zagreb School of Medicine</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Dario Gulin, Klini&#x010D;ka bolnica &#x201E;Sveti Duh&#x201C;, Sv. Duh 64, HR-10000 Zagreb, Croatia. Phone: +385-91-3712-398 / E-mail: <email xlink:href="dariogulin@gmail.com">dariogulin@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>06</month><year>2018</year></pub-date>
<volume>13</volume>
<issue>5-6</issue>
<fpage>183</fpage>
<lpage>183</lpage>
<history>
<date date-type="received"><day>04</day><month>05</month><year>2018</year></date><date date-type="accepted"><day>10</day><month>05</month><year>2018</year></date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>mitral regurgitation</kwd><kwd>primary</kwd><kwd>gender</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction:</bold> Mitral regurgitation (MR) represents the second most common valvular heart disease (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). It is classified as primary (organic) and secondary (functional) MR, with secondary being more frequent (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). Degenerative valvular disease, rheumatic fever, infective endocarditis and mitral valve prolapse are most common causes of primary MR<bold><sup>2</sup></bold>. On the other hand, secondary MR is usually result of ischemic heart disease or dilatative cardiomyopathy (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). The aim of our study was to investigate the incidence of primary MR according to gender.</p>
<p><bold>Patients and Methods:</bold> Retrospective study was conducted to assess the relation between MR with other VHD. A total of 686 patients, with male predominance of 55%, were included in the study.</p>
<p><bold>Results:</bold> Among all patients with MR 519 (75.6%) had primary MR. Degenerative valvular heart disease was the main cause of primary MR, counting for 474 patients (91.3%). Other causes of primary MR included mitral valve prolapse, rheumatic valvular heart disease, and other causes, with frequency of 19 (3.6%), 5 (1%), 21 (4.1%), respectively. According to gender distribution, 290 (55.9%) males and 229 (44.1%) females had primary MR. Degenerative mitral valve disease was the main cause of primary MR in both men and women (90.3 and 92.5%), while the least frequent was infective endocarditis among men and rheumatic heart disease among women.</p>
<p><bold>Conclusion:</bold> Degenerative MR was most common cause of primary MR. Regardless of gender groups, with women slightly more affected.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andell</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Martinsson</surname><given-names>A</given-names></name><name><surname>Andersson</surname><given-names>C</given-names></name><name><surname>Stagmo</surname><given-names>M</given-names></name><name><surname>Z&#x00F6;ller</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.</article-title> <source>Heart</source>. <year>2017</year> Nov;<volume>103</volume>(<issue>21</issue>):<fpage>1696</fpage>&#x2013;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2016-310894</pub-id><pub-id pub-id-type="pmid">28432156</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okura</surname><given-names>H</given-names></name><name><surname>Kataoka</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name></person-group>. <article-title>Renin-angiotensin system inhibitors in patients with myocardial infarction and secondary mitral regurgitation.</article-title> <source>Heart</source>. <year>2016</year> May;<volume>102</volume>(<issue>9</issue>):<fpage>694</fpage>&#x2013;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-308536</pub-id><pub-id pub-id-type="pmid">26864671</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
